RENOVORX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.45 USD | +7.81% |
|
+18.85% | -36.68% |
Chart calendar RenovoRx, Inc.
2da252db2.SGcVljnusPIwFrmplaZTZwTQXWmFjta_079APJJo_2k.PDZB-3utxMJCcvjtodUjI0njExuzvoTvmsclC9MGsw19JGH0ftnmlwBn3g~c1bc9f04cd170be85112cdceaa915b81
Upcoming events on RenovoRx, Inc.
Past events on RenovoRx, Inc.
| 09/05/2024 08:00 pm | Aegis Capital Virtual Conference |
| 15/04/2024 05:30 pm | CG Horizons in Oncology Virtual Conference |
| 23/03/2024 | Society Of Interventional Radiology Scientific Meeting - Abstract No:1632169 |
| 19/03/2024 10:30 pm | Roth Conference |
| 15/12/2023 11:30 pm | Extraordinary Shareholders Meeting |
| 14/11/2023 07:00 pm | Q3 2023 Earnings Release |
| 12/10/2023 09:00 pm | Roth Healtcare Opportunities Conference |
| 17/08/2023 06:00 pm | Q2 2023 Earnings Release |
| 10/08/2023 08:00 pm | Canaccord Genuity Growth Conference |
| 29/06/2023 12:20 pm | ESMO Gastrointestinal Cancer World Congress - Abstract Number : LBA-1 |
| 15/06/2023 07:30 pm | Investor Meeting - Key Opinion Leader |
| 08/06/2023 09:30 pm | Annual General Meeting |
| 07/06/2023 01:30 am | LD Micro Invitational Conference |
| 15/05/2023 06:00 pm | Q1 2023 Earnings Release |
| 04/05/2023 01:00 am | Aegis Capital Virtual Conference |
| 17/04/2023 06:30 pm | American Association for Cancer Research Meeting |
| 14/03/2023 02:30 am | Roth Conference |
| 02/03/2023 06:00 pm | Q4 2022 Earnings Release |
| 03/02/2023 02:30 am | Sequire Biotechnology Conference |
| 19/01/2023 | American Society of Clinical Oncology Gastrointestinal Cancers Symposium |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -5,67 -4,53 -25.1% | -9,95 -10,2 2.33% | -11,4 -12,9 11.87% | -8,55 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -6,32 -5,36 -17.92% | -9,89 -10,1 2.11% | -10,2 -10,3 0.82% | -8,12 |
|
Net income Million USD | Released Forecast Spread | -3,80 | -6,32 -5,36 -17.92% | -9,89 -10,1 2.11% | -10,2 -10,3 0.82% | -8,12 |
|
EPS USD | Released Forecast Spread | -0,34 | -1,21 -1,24 2.42% | -1,09 -1,12 2.24% | -0,99 -1,01 1.49% | -0,32 |
| Announcement Date | 02/04/21 | 30/03/22 | 02/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -2,36 -1,22 -93.27% | -3,01 -2,02 -48.73% | -2,61 -2,63 0.42% | -2,16 -2,67 19.2% | -2,17 -2,41 9.85% | -3,26 -2,38 -36.82% | -3,38 -2,97 -13.5% | -2,98 -3,34 10.77% | -1,78 -3,31 46.35% | -2,48 -2,25 -10.04% | -2,10 | -2,10 | -2,10 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,36 -1,39 -68.94% | -3,00 -1,98 -51.44% | -2,59 -2,60 0.04% | -2,14 -2,64 19.23% | -2,16 -2,37 9.01% | -3,26 -2,37 -37.37% | -2,33 -2,96 21.41% | -1,42 -3,33 57.33% | -3,23 -3,31 2.57% | -1,08 -2,19 50.76% | -1,96 | -1,98 | -1,99 | |
|
Net income Million USD | Released Forecast Spread | -2,36 -1,39 -68.94% | -3,00 -1,98 -51.44% | -2,59 -2,60 0.04% | -2,14 -2,64 19.23% | -2,16 -2,37 9.01% | -3,26 -2,37 -37.37% | -2,33 -2,96 21.41% | -1,42 -3,33 57.33% | -3,23 -3,31 2.57% | -1,08 -2,19 50.76% | -1,96 | -1,98 | -1,99 | |
|
EPS USD | Released Forecast Spread | -0,12 -0,19 36.84% | -0,33 -0,21 -57.14% | -0,29 -0,29 -1.75% | -0,24 -0,29 17.24% | -0,23 -0,26 11.54% | -0,36 -0,22 -67.44% | -0,22 -0,29 24.14% | -0,13 -0,28 53.57% | -0,30 -0,31 1.64% | -0,07 -0,13 46.15% | -0,08 | -0,07 | -0,07 | |
| Announcement Date | 30/03/22 | 13/05/22 | 12/08/22 | 14/11/22 | 02/03/23 | 12/05/23 | 16/08/23 | 13/11/23 | 01/04/24 | 10/05/24 | - | - | - | - |
More events
Past sector events for RenovoRx, Inc.
| 11/05/2024 01:32 am | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
| 10/05/2024 05:56 pm | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 05:30 pm | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
| 10/05/2024 04:30 pm | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 05:35 am | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 01:45 am | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:40 am | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:39 am | XENCOR, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RNXT Stock
- Calendar RenovoRx, Inc.
